Algen Biotechnologies
Using CRISPR to find treatments for cancer and inflammation
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
Algen is using CRISPR to uncover disease-driving RNA messages to find treatments for cancer, inflammation and diseases with high unmet needs. We are harnessing the power of CRISPR and machine learning to find first-in-class drugs that modulate RNA messages at single-cell resolution. Algen's founders are bioengineer from Jennifer Doudna Lab and biotech commercialization expert, teamed up with experienced pharmaceutical executives. Algen Biotechnologies is a Y Combinator company (Winter 2020). YC-listed status: Active.
- Website
- algenbio.com
- Location
- San Francisco, CA, USA
- Added via
- web
- Ownership
- unclaimed
Where to go
Products
- Algen Biotechnologies — CRISPR and AI drug discovery platform that identifies disease-driving RNA signaling pathways at single-cell resolution. · Service
Links
- Y Combinator profileycombinator